首页> 外文OA文献 >PND39 What is the Influence on Clinical Research of the EMA Guideline on Medicinal Products for the Treatment of Alzheimer's Disease?

【2h】

PND39 What is the Influence on Clinical Research of the EMA Guideline on Medicinal Products for the Treatment of Alzheimer's Disease?

机译：PND39对用于治疗阿尔茨海默氏病的药品的EMA指南的临床研究有什么影响？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Caron M.; Acquadro C.; Emery M.P.;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Commentary on the EMA Guideline EMA Guideline on strategies to identify and mitigate risks for first‐in‐human and early clinical trials with investigational medicinal products [J] . Gerven Joop, Bonelli Milton British Journal of Clinical Pharmacology . 2018,第7期

机译：EMA指南EMA指南识别和减轻与调查药品的先发制人和早期临床试验风险的策略指南的评论
2. ESCEO CONSENSUS ADVICE TO EMA REGARDING THE DRAFT GUIDELINES ON CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF RA [J] . Boers M. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2017,第Suppla1期

机译：esceo关于EMA的咨询，了解有关用于治疗RA的药品临床调查准则草案
3. ESCEO CONSENSUS ADVICE TO EMA REGARDING THE DRAFT GUIDELINES ON CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF RA [J] . Boers M. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2017,第Suppla1期

机译：esceo关于EMA的咨询，了解有关用于治疗RA的药品临床调查准则草案
4. Clinical Practice Guidelines and Comorbid Diseases: A MiniZinc Representation of Guideline Models for Mitigating Adverse Interactions [C] . Szymon Wilk, Martin Michalowski, Wojtek Michalowski, MEDINFO . 2013

机译：临床实践指南和合并症疾病：用于减轻不利互动的指南模型的迷你智能
5. Investigations of S-glutathionylation of brain proteins in the progression of Alzheimer's disease and of a potential glutathione mimetic as a treatment of Alzheimer's disease [D] . Newman, Shelley Faye 2008

机译：阿尔茨海默氏病进展过程中脑蛋白S-谷胱甘肽酰化的研究以及潜在的谷胱甘肽模拟物治疗阿尔茨海默氏病的研究
6. Commentary on the EMA Guideline on strategies to identify and mitigate risks for first‐in‐human and early clinical trials with investigational medicinal products [O] . Joop van Gerven, Milton Bonelli 2018

机译：关于EMA指南的评论该指南旨在确定和减轻使用研究性药物进行的首次人类和早期临床试验的风险
7. P465 UC trial designed more than 5 years ago in the light of the EMA guideline on the development of new medicinal products for the treatment of ulcerative colitis [O] . R Laoun, R Hofmann 2019

机译：P465 UC审判设计了超过5年前的鉴于EMA关于开发新药产品的溃疡性结肠炎的指导方针
8. Recognition and Initial Assessment of Alzheimer's Disease and Related Dementias.Clinical Practice Guideline Number 19; Early Identification of Alzheimer's Disease and Related Dementias. Quick Reference Guide for Clinicians Number 19; Early Alzheimer's Dis [R] . Costa, P. T., Williams, T. F., Albert, M. S., 1996

机译：阿尔茨海默病和相关痴呆的认可和初步评估。临床实践指南第19号;阿尔茨海默病及相关痴呆的早期鉴定。临床医生快速参考指南第19号;早期阿尔茨海默氏症

PND39 What is the Influence on Clinical Research of the EMA Guideline on Medicinal Products for the Treatment of Alzheimer's Disease?

著录项

引文网络

相似文献

相关主题

期刊订阅